Skip to main content

Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.

Publication ,  Journal Article
DerHovanessian, A; Todd, JL; Zhang, A; Li, N; Mayalall, A; Finlen Copeland, CA; Shino, M; Pavlisko, EN; Wallace, WD; Gregson, A; Ross, DJ ...
Published in: Ann Am Thorac Soc
May 2016

RATIONALE: The clinical course of chronic lung allograft dysfunction (CLAD) is heterogeneous. Forced vital capacity (FVC) loss at onset, which may suggest a restrictive phenotype, was associated with worse survival for bilateral lung transplant recipients in one previously published single-center study. OBJECTIVES: We sought to replicate the significance of FVC loss in an independent, retrospectively identified cohort of bilateral lung transplant recipients and to investigate extended application of this approach to single lung recipients. METHODS: FVC loss and other potential predictors of survival after the onset of CLAD were assessed using Kaplan-Meier and Cox proportional hazards models. MEASUREMENTS AND MAIN RESULTS: FVC loss at the onset of CLAD was associated with higher mortality in an independent cohort of bilateral lung transplant recipients (hazard ratio [HR], 2.75; 95% confidence interval [CI], 2.02-3.73; P < 0.0001) and in a multicenter cohort of single lung recipients (HR, 1.80; 95% CI, 1.09-2.98; P = 0.02). Including all subjects, the deleterious impact of FVC loss on survival persisted after adjustment for other relevant clinical variables (HR, 2.36; 95% CI, 1.77-3.15; P < 0.0001). In patients who develop CLAD without FVC loss, chest computed tomography features suggestive of pleural or parenchymal fibrosis also predicted worse survival in both bilateral (HR, 2.01; 95% CI, 1.16-5.20; P = 0.02) and single recipients (HR, 2.47; 95% CI, 1.24-10.57; P = 0.02). CONCLUSIONS: We independently validated the prognostic significance of FVC loss for bilateral lung recipients and demonstrated that this approach to CLAD classification also confers prognostic information for single lung transplant recipients. Improved understanding of these discrete phenotypes is critical to the development of effective therapies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Am Thorac Soc

DOI

EISSN

2325-6621

Publication Date

May 2016

Volume

13

Issue

5

Start / End Page

627 / 635

Location

United States

Related Subject Headings

  • Vital Capacity
  • United States
  • Tomography, X-Ray Computed
  • Survival Analysis
  • Risk Factors
  • Retrospective Studies
  • Prognosis
  • Primary Graft Dysfunction
  • Phenotype
  • Middle Aged
 

Citation

APA
Chicago
ICMJE
MLA
NLM
DerHovanessian, A., Todd, J. L., Zhang, A., Li, N., Mayalall, A., Finlen Copeland, C. A., … Weigt, S. S. (2016). Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients. Ann Am Thorac Soc, 13(5), 627–635. https://doi.org/10.1513/AnnalsATS.201510-719OC
DerHovanessian, Ariss, Jamie L. Todd, Alice Zhang, Ning Li, Aradhna Mayalall, C Ashley Finlen Copeland, Michael Shino, et al. “Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.Ann Am Thorac Soc 13, no. 5 (May 2016): 627–35. https://doi.org/10.1513/AnnalsATS.201510-719OC.
DerHovanessian A, Todd JL, Zhang A, Li N, Mayalall A, Finlen Copeland CA, et al. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients. Ann Am Thorac Soc. 2016 May;13(5):627–35.
DerHovanessian, Ariss, et al. “Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.Ann Am Thorac Soc, vol. 13, no. 5, May 2016, pp. 627–35. Pubmed, doi:10.1513/AnnalsATS.201510-719OC.
DerHovanessian A, Todd JL, Zhang A, Li N, Mayalall A, Finlen Copeland CA, Shino M, Pavlisko EN, Wallace WD, Gregson A, Ross DJ, Saggar R, Lynch JP, Belperio J, Snyder LD, Palmer SM, Weigt SS. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients. Ann Am Thorac Soc. 2016 May;13(5):627–635.

Published In

Ann Am Thorac Soc

DOI

EISSN

2325-6621

Publication Date

May 2016

Volume

13

Issue

5

Start / End Page

627 / 635

Location

United States

Related Subject Headings

  • Vital Capacity
  • United States
  • Tomography, X-Ray Computed
  • Survival Analysis
  • Risk Factors
  • Retrospective Studies
  • Prognosis
  • Primary Graft Dysfunction
  • Phenotype
  • Middle Aged